Research
Hormonal
Leptin-replacement therapy significantly improves glycemic control, reduces triglyceride levels, and decreases liver volume in patients with lipodystrophy and leptin deficiency.
If you have a rare condition called lipodystrophy that causes a severe lack of body fat and leptin, leptin replacement therapy can dramatically improve your blood sugar, lower dangerous triglyceride levels, and shrink your liver. This treatment is not for general obesity but is a critical therapy for this specific hormonal deficiency.
GoodSupportsHIGH confidence
Leptin-replacement therapy improved glycemic control and decreased triglyceride levels in patients with lipodystrophy and leptin deficiency.
Why this rating
Small sample size (n=9) and open-label design, but robust statistical significance and clear physiological outcomes.
Source
Leptin-Replacement Therapy for Lipodystrophy
Elif A Oral et al. · New England Journal of Medicine · 2002
DOI 10.1056/nejmoa012437
clinical_trial · n=9Cited 1,233×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →